Novavax Inc (NVAX) is higher by Friday morning, with the stock gaining 1.27% in pre-market trading to 5.57. NVAX's short-term technical score of 21 indicates that the stock has traded less bullishly over the last month than 79% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, the stock ranks higher than 35% of stocks. Novavax Inc has fallen 17.42% over the past month, closing at $7.06 on November 3. During this period of time, the stock fell as low as $5.35 and as high as $7.49. NVAX has an average analyst recommendation of Buy. The company has an average price target of $19.60.
NVAX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on NVAX!